Literature DB >> 22661698

Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice.

Simon Bélanger1, Megan M Tu, Mir Munir Ahmed Rahim, Ahmad B Mahmoud, Rajen Patel, Lee-Hwa Tai, Angela D Troke, Brian T Wilhelm, Josette-Renée Landry, Qinzhang Zhu, Kenneth S Tung, David H Raulet, Andrew P Makrigiannis.   

Abstract

Ly49-mediated recognition of MHC-I molecules on host cells is considered vital for natural killer (NK)-cell regulation and education; however, gene-deficient animal models are lacking because of the difficulty in deleting this large multigene family. Here, we describe NK gene complex knockdown (NKC(KD)) mice that lack expression of Ly49 and related MHC-I receptors on most NK cells. NKC(KD) NK cells exhibit defective killing of MHC-I-deficient, but otherwise normal, target cells, resulting in defective rejection by NKC(KD) mice of transplants from various types of MHC-I-deficient mice. Self-MHC-I immunosurveillance by NK cells in NKC(KD) mice can be rescued by self-MHC-I-specific Ly49 transgenes. Although NKC(KD) mice display defective recognition of MHC-I-deficient tumor cells, resulting in decreased in vivo tumor cell clearance, NKG2D- or antibody-dependent cell-mediated cytotoxicity-induced tumor cell cytotoxicity and cytokine production induced by activation receptors was efficient in Ly49-deficient NK cells, suggesting MHC-I education of NK cells is a single facet regulating their total potential. These results provide direct genetic evidence that Ly49 expression is necessary for NK-cell education to self-MHC-I molecules and that the absence of these receptors leads to loss of MHC-I-dependent "missing-self" immunosurveillance by NK cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661698      PMCID: PMC3976224          DOI: 10.1182/blood-2012-02-408732

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  38 in total

1.  Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element.

Authors:  Dawn M Tanamachi; Deborah C Moniot; Dragana Cado; Scot D Liu; Jennifer K Hsia; David H Raulet
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

2.  Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation.

Authors:  Ali Saleh; Gareth E Davies; Veronique Pascal; Paul W Wright; Deborah L Hodge; Edward H Cho; Stephen J Lockett; Mehrnoosh Abshari; Stephen K Anderson
Journal:  Immunity       Date:  2004-07       Impact factor: 31.745

3.  Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

Authors:  A Diefenbach; A M Jamieson; S D Liu; N Shastri; D H Raulet
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

4.  NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules.

Authors:  L Corral; T Hanke; R E Vance; D Cado; D H Raulet
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

5.  YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.

Authors:  G E Piontek; K Taniguchi; H G Ljunggren; A Grönberg; R Kiessling; G Klein; K Kärre
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

6.  A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice.

Authors:  Andrew P Makrigiannis; Amanda T Pau; Pamela L Schwartzberg; Daniel W McVicar; Thomas W Beck; Stephen K Anderson
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

7.  The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis.

Authors:  Eugene Y Chiang; Maile Henson; Iwona Stroynowski
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

8.  Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

Authors:  K Kärre; H G Ljunggren; G Piontek; R Kiessling
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

9.  Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.

Authors:  Atsushi Tajima; Toshitaka Tanaka; Tomohiko Ebata; Kazuyoshi Takeda; Akemi Kawasaki; Janice M Kelly; Phillip K Darcy; Russell E Vance; David H Raulet; Katsuyuki Kinoshita; Ko Okumura; Mark J Smyth; Hideo Yagita
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

10.  Role of Qa-1(b)-binding receptors in the specificity of developing NK cells.

Authors:  M Salcedo; F Colucci; P J Dyson; L A Cotterill; F A Lemonnier; P Kourilsky; J P Di Santo; H G Ljunggren; J P Abastado
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

View more
  28 in total

1.  Ly49 receptors activate angiogenic mouse DBA⁺ uterine natural killer cells.

Authors:  Patricia D A Lima; Megan M Tu; Mir Munir A Rahim; Annie R Peng; B Anne Croy; Andrew P Makrigiannis
Journal:  Cell Mol Immunol       Date:  2014-06-23       Impact factor: 11.530

2.  Critical role for the Ly49 family of class I MHC receptors in adaptive natural killer cell responses.

Authors:  Andrew Wight; Ahmad Bakur Mahmoud; Michal Scur; Megan M Tu; Mir Munir A Rahim; Subash Sad; Andrew P Makrigiannis
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-24       Impact factor: 11.205

Review 3.  Clinical utility of natural killer cells in cancer therapy and transplantation.

Authors:  David A Knorr; Veronika Bachanova; Michael R Verneris; Jeffrey S Miller
Journal:  Semin Immunol       Date:  2014-03-05       Impact factor: 11.130

4.  Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor.

Authors:  Michael D Bern; Diana L Beckman; Takashi Ebihara; Samantha M Taffner; Jennifer Poursine-Laurent; J Michael White; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

5.  The mouse NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responses.

Authors:  Mir Munir A Rahim; Peter Chen; Amelia N Mottashed; Ahmad Bakur Mahmoud; Midhun J Thomas; Qinzhang Zhu; Colin G Brooks; Vicky Kartsogiannis; Matthew T Gillespie; James R Carlyle; Andrew P Makrigiannis
Journal:  Blood       Date:  2015-01-22       Impact factor: 22.113

6.  Dynamic variability in SHP-1 abundance determines natural killer cell responsiveness.

Authors:  Zeguang Wu; Soo Park; Colleen M Lau; Yi Zhong; Sam Sheppard; Joseph C Sun; Jayajit Das; Grégoire Altan-Bonnet; Katharine C Hsu
Journal:  Sci Signal       Date:  2021-11-09       Impact factor: 8.192

Review 7.  The Role of NK Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia.

Authors:  Alireza Zafarani; Mahsa Taghavi-Farahabadi; Mohammad Hossein Razizadeh; Mohammad Reza Amirzargar; Mansoure Mansouri; Mohammad Mahmoudi
Journal:  Stem Cell Rev Rep       Date:  2022-08-22       Impact factor: 6.692

8.  NKR-P1B expression in gut-associated innate lymphoid cells is required for the control of gastrointestinal tract infections.

Authors:  Elias Abou-Samra; Zachary Hickey; Oscar A Aguilar; Michal Scur; Ahmad Bakur Mahmoud; Sergey Pyatibrat; Megan M Tu; Jeffrey Francispillai; Arthur Mortha; James R Carlyle; Mir Munir A Rahim; Andrew P Makrigiannis
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

9.  A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice.

Authors:  Gabriela Maria Wiedemann; Severin Johannes Jacobi; Michael Chaloupka; Angelina Krächan; Svetlana Hamm; Stefan Strobl; Roland Baumgartner; Simon Rothenfusser; Peter Duewell; Stefan Endres; Sebastian Kobold
Journal:  Oncoimmunology       Date:  2016-05-31       Impact factor: 8.110

10.  Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire.

Authors:  Sam Sheppard; Chiara Triulzi; Michele Ardolino; Daniel Serna; Lily Zhang; David H Raulet; Nadia Guerra
Journal:  Blood       Date:  2013-05-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.